Literature DB >> 3514758

Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.

B P Morgan, D K Imagawa, J R Dankert, L E Ramm.   

Abstract

Previous studies have demonstrated that in general, nucleated cells are more resistant to killing by serum complement than are erythrocytes. During studies aimed at defining the mechanisms of nucleated cell resistance, we found that the human histiocytic cell line U937 was easily lysed by homologous serum. U937 cells were also killed by serum depleted of C9, but not by serum depleted of C8, implying that the C5b-8 complex was sufficient to cause lysis of these cells. Enumeration of complexes on the cell surface demonstrated that approximately 40-fold more complexes were required to lyse U937 cells in the absence of C9 than in the presence of an excess of C9. Examination of the effects of small amounts of C9 on lysis of U937 cells by the C5b-8 complex demonstrated that at very low doses, C9 inhibited C5b-8 mediated lysis. The use of radiolabeled anti-C8 antibody showed that C5b-8 complexes were eliminated from the surface of U937 cells at 37 degrees C, and C9 at the dose causing inhibition of lysis accelerated the elimination of complexes. These results suggest that the increased lytic potential resulting from binding of small amounts of C9 to C5b-8 complexes is outweighed by enhanced elimination of complexes resulting in decreased cell death.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514758

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Mesenchymal stem cells are injured by complement after their contact with serum.

Authors:  Yan Li; Feng Lin
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

Review 2.  Emission of membrane vesicles: roles in complement resistance, immunity and cancer.

Authors:  David Pilzer; Olivier Gasser; Oren Moskovich; Jurg A Schifferli; Zvi Fishelson
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

3.  Killing of human melanoma cells by the membrane attack complex of human complement as a function of its molecular composition.

Authors:  D E Martin; F J Chiu; I Gigli; H J Müller-Eberhard
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

4.  Antibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions.

Authors:  Erika M Cook; Margaret A Lindorfer; Hilma van der Horst; Simone Oostindie; Frank J Beurskens; Janine Schuurman; Clive S Zent; Richard Burack; Paul W H I Parren; Ronald P Taylor
Journal:  J Immunol       Date:  2016-07-29       Impact factor: 5.422

Review 5.  Membrane attack by complement: the assembly and biology of terminal complement complexes.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Snehal Patel; Richard Trippe; Violeta Rus; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

6.  Caveolin-1 and dynamin-2 are essential for removal of the complement C5b-9 complex via endocytosis.

Authors:  Oren Moskovich; Lee-Or Herzog; Marcelo Ehrlich; Zvi Fishelson
Journal:  J Biol Chem       Date:  2012-04-23       Impact factor: 5.157

7.  Presence of a dysfunctional form of CD59 on a CD59+ subclone of the U937 cell line.

Authors:  C W van den Berg; O M Williams; B P Morgan
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

8.  Mechanism of killing of Giardia lamblia trophozoites by complement.

Authors:  M Deguchi; F D Gillin; I Gigli
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

9.  Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).

Authors:  T Seya; T Hara; M Matsumoto; Y Sugita; H Akedo
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

10.  Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice.

Authors:  Xiaoyan Fu; Jiyu Ju; Zhijuan Lin; Weiling Xiao; Xiaofang Li; Baoxiang Zhuang; Tingting Zhang; Xiaojun Ma; Xiangyu Li; Chao Ma; Weiliang Su; Yuqi Wang; Xuebin Qin; Shujuan Liang
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.